Turnstone Biologics
Turnstone Biologics is an oncolytic viral immunotherapy founded in 2015.
2
Funding Rounds
$121.4m
Money raised
Overview
Turnstone Biologics is an oncolytic viral immunotherapy founded in 2015.
-
Website:
- Business model: B2B
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| sa*** fa*** | - | - | |
| je*** da*** | - | - | |
| mi** bu | - | - |
Funding
Funding series
Funding Series Analysis
The company Turnstone Biologics has raised a total of $121.4m in funding over 2 rounds.
Key Insights:
- Turnstone Biologics Series D round: $80m
- Turnstone Biologics Series B round, November 2016: $41.4m
Turnstone Biologics Series D round
$80m
Turnstone Biologics Series B round, November 2016
$41.4m
Industries
Turnstone Biologics is active in the following industries: